Pharmaceutical Patent Analyst

期刊简介：This journal has ceased (2025). Pharmaceutical Patent Analyst is dedicated to making the essential content of key patents available in a concise and enriched format to researchers and other specialists, while also providing timely commentary on important issues related to patent and IP law. As one of the main drivers of innovation, in both academia and industry, patents are a rich source of technical information about the latest advances in the discovery and design of novel therapeutics and healthcare products. The journal’s core content therefore comprises high-impact patent reviews that provide an objective and concise appraisal of selected patents in a chosen area, set within the context of the wider relevant R&D landscape. Articles exploring patenting trends as well as those examining new methodologies for searching the patent literature also feature. Complementing the core scientific review content of each issue are news updates, editorials, interviews and hot topic articles presenting enlightened opinion and commentary on pressing IP issues related to the pharmaceutical patent life-cycle or to R&D more broadly. Audience Pharmaceutical Patent Analyst is principally targeted at researchers and scientists who need to remain abreast of developments in the patent literature, while additionally enhancing their understanding of associated IP issues. In addition, the journal will appeal to those outside the research community, notably IP specialists, legal professionals and technology-transfer officers. Coverage in brief The journal publishes a variety of article types as indicated below. More details can be found here. For further information or to contribute an article, please contact the Editor. Analyses of the patent literature: Reviews examining patents of relevance to all therapeutic areas will be accepted, including: Chemical and biological entities of therapeutic significance Healthcare products (e.g., medical devices and drug-delivery systems) Drug-discovery and design technologies Inventions in related disciplines (e.g., biotechnology and nanotechnology) Articles dedicated to the following will also be considered: Analyses of patenting trends for selected patent classes, therapeutic areas or geographic regions Design and application of novel methodologies for searching and analysing the patent literature The journal welcomes unsolicited article proposals.

【译文】该期刊已停刊（2025）。医药专利分析师致力于以简洁、丰富的形式向研究人员和其他专家提供关键专利的基本内容，同时还对与专利和知识产权法相关的重要问题提供及时的评论。作为学术界和工业界创新的主要驱动力之一，专利是有关新型疗法和医疗保健产品的发现和设计最新进展的丰富技术信息来源。因此，该杂志的核心内容包括高影响力的专利评论，这些评论在更广泛的相关研发领域的背景下，对选定领域的选定专利进行客观而简洁的评估。探讨专利趋势以及研究专利文献检索新方法的文章也很重要。作为对每期核心科学评论内容的补充，新闻更新、社论、采访和热门话题文章针对与药品专利生命周期或更广泛的研发相关的紧迫知识产权问题提出了开明的观点和评论。 Audience Pharmaceutical Patent Analyst 主要针对需要及时了解专利文献发展的研究人员和科学家，同时还需要增强他们对相关知识产权问题的理解。此外，该期刊还将吸引研究界以外的人士，特别是知识产权专家、法律专业人士和技术转让官员。报道范围简介 该期刊发表了多种类型的文章，如下所示。更多详细信息可以在这里找到。如需更多信息或撰写文章，请联系编辑。专利文献分析： 审查与所有治疗领域相关的专利的审查将被接受，包括： 具有治疗意义的化学和生物实体 医疗保健产品（例如，医疗器械和药物输送系统） 药物发现和设计技术 相关学科的发明（例如，生物技术和纳米技术） 还将考虑致力于以下内容的文章： 分析选定专利类别、治疗领域或地理区域的专利趋势 分析专利文献的新颖方法的设计和应用 期刊欢迎主动提出文章建议。